Background Two-stage least square [2SLS] and two-stage residual inclusion [2SRI] are popularly used instrumental variable (IV) methods to address medication nonadherence in pragmatic trials with point treatment settings. These methods require assumptions, e.g., exclusion restriction, although they are known to handle unmeasured confounding. The newer IV-method, nonparametric causal bound [NPCB], showed promise in reducing uncertainty compared to usual IV-methods. The inverse probability-weighted per-protocol [IP-weighted PP] method is useful in the same setting but requires different assumptions, e.g., no unmeasured confounding. Although all of these methods are aimed to address the same nonadherence problem, comprehensive ...
Objective: To undertake a methodological review of statistical methods used in randomized controlle...
Objectives Randomization can be used as an instrumental variable (IV) to account for unmeasured conf...
International audienceBACKGROUND:In pharmacoepidemiology, the prescription preference-based instrume...
Introduction: The instrumental variable (IV)-based methods (e.g., two-stage least square [2SLS], two...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Unmeasured confounding is a common concern when clinical and health services researchers attempt to ...
Unmeasured confounding is a common concern when clinical and health services researchers attempt to ...
Abstract Objectives In pragmatic trials, the new treatment is compared with usual care (heterogeneou...
Objective: To undertake a methodological review of statistical methods used in randomized controlle...
Objectives Randomization can be used as an instrumental variable (IV) to account for unmeasured conf...
International audienceBACKGROUND:In pharmacoepidemiology, the prescription preference-based instrume...
Introduction: The instrumental variable (IV)-based methods (e.g., two-stage least square [2SLS], two...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Unmeasured confounding is a common concern when clinical and health services researchers attempt to ...
Unmeasured confounding is a common concern when clinical and health services researchers attempt to ...
Abstract Objectives In pragmatic trials, the new treatment is compared with usual care (heterogeneou...
Objective: To undertake a methodological review of statistical methods used in randomized controlle...
Objectives Randomization can be used as an instrumental variable (IV) to account for unmeasured conf...
International audienceBACKGROUND:In pharmacoepidemiology, the prescription preference-based instrume...